We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current 0FDB market cap is 208.46M. The company's latest EPS is NOK 1.7083 and P/E is 7.08.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | |
| Total Revenue | 184.02M | 188.85M | 209.88M | 278.44M | 382.14M |
| Operating Income | -4.57M | -20.49M | -9.45M | 17.97M | 67.6M |
| Net Income | 7.28M | 27.94M | -16.46M | 619k | 29.43M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | |
| Total Assets | 214.73M | 187.06M | 260.04M | 330.18M | 382.77M |
| Total Liabilities | 115.41M | 107.83M | 130.55M | 178.94M | 173.05M |
| Total Equity | 99.32M | 79.23M | 129.49M | 151.24M | 209.72M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | |
| Operating | -36.02M | 12.72M | -3.18M | -1.3M | 17.94M |
| Investing | -2.16M | -1.87M | -23.14M | -727k | -25.44M |
| Financing | 20.37M | -10.9M | 51.76M | 15.93M | 10.07M |
| Market Cap | 208.46M |
| Price to Earnings Ratio | 7.08 |
| Price to Sales Ratio | 0.55 |
| Price to Cash Ratio | 3.84 |
| Price to Book Ratio | 0.99 |
| Dividend Yield | - |
| Shares Outstanding | 17.23M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 0.00% |
| 52 Week High | 12.10 |
| 52 Week Low | 12.10 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Navamedic Asa |
| Address |
fornebuveien 42-44 lysaker N-1325 |
| Website | https://www.navamedic.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
